Dopamine transporter genotype as a risk factor for obesity in African-American smokers - PubMed (original) (raw)
. 2002 Dec;10(12):1232-40.
doi: 10.1038/oby.2002.168.
Affiliations
- PMID: 12490667
- DOI: 10.1038/oby.2002.168
Free article
Dopamine transporter genotype as a risk factor for obesity in African-American smokers
Leonard H Epstein et al. Obes Res. 2002 Dec.
Free article
Abstract
Objective: To assess the association between a polymorphism related to dopamine function, dopamine transport (SLC6A3), and obesity in smokers.
Research methods and procedures: Logistic regression was used to assess the relationship between this genetic polymorphism and obesity (body mass index > or = 30 kg/m(2)) from a sample of 510 smokers who smoked at least 10 cigarettes per day and who were participating in a study designed to examine genetic and nongenetic predictors of response to a pharmacological treatment.
Results: The likelihood of obesity in African Americans (N = 90) with the 10/10 SLC6A3 genotype was 5.16 times that of African Americans with 9/9 or 9/10 SLC6A3 genotypes (odds ratio = 5.16, confidence interval = 1.60 to 16.65). There was no association of the SLC6A3 genotype with obesity for non-Hispanic whites (N = 420).
Discussion: These results suggest that variants of the dopamine transporter gene may be related to obesity in African-American smokers. Possible mechanisms responsible for the association between dopamine transport and obesity in African-American smokers are discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical